View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Danone SA announces the purchase of c.5.8 million of its own shares he...

Danone SA announces the purchase of c.5.8 million of its own shares held by its Spanish subsidiary, with no impact on total Danone shares held by the Group                                                                    Press release - Paris, December 17, 2025, at 7:00 PM CET Danone SA announces the purchase of c.5.8 million of its own shares held by its Spanish subsidiary, with no impact on total Danone shares held by the Group As part of the simplification of its corporate structure, Danone SA purchased on December 17, 2025, all 5,780,005 of its own shares previously held by its S...

 PRESS RELEASE

Danone annonce le rachat d’environ 5,8 millions de ses propres actions...

Danone annonce le rachat d’environ 5,8 millions de ses propres actions détenues par sa filiale espagnole, sans impact sur le nombre total d’actions Danone détenues par le groupe Communiqué de presse - Paris, le 17 décembre 2025, à 19h00 Danone annonce le rachat d’environ 5,8 millions de ses propres actions détenues par sa filiale espagnole, sans impact sur le nombre total d’actions Danone détenues par le groupe Dans le cadre de la simplification de sa structure juridique, Danone SA a procédé le 17 décembre 2025 au rachat de l’intégralité des 5 780 005 actions précédemment détenues par sa ...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Thematic - 2026 Outlook - "5 More Years" (55pgs)

For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...

Delphine Brault ... (+2)
  • Delphine Brault
  • Nathan Mietlicki

ODDO : Nous favorisons Metso pour jouer la reprise des investissements...

Nous réinitions la couverture de Metso à Surperformance, Sandvik à Neutre et Epiroc à Sous-performance. Notre scénario 2026 table sur un retour de la croissance des investissements miniers (+6.8%), une reprise progressive des infrastructures (commandes attendues à +7% en organique chez Metso pour Aggregates) et des activités à cycle court (commandes SMM chez Sandvik estimées à +5.5%). Dans ce contexte, nous favorisons Metso pour son meilleur positionnement (pipeline greenfield et infrastructures...

Delphine Brault ... (+2)
  • Delphine Brault
  • Nathan Mietlicki

ODDO : We favour Metso to play the recovery of investments in 2026

We reinitiate coverage with Metso at Outperform, Sandvik at Neutral and Epiroc at Underperform. Our 2026 scenario is based on a return to growth in mining investment (+6.8%), a gradual recovery in infrastructure (orders expected to rise by +7% organically at Metso for Aggregates) and short-cycle activities (SMM orders at Sandvik estimated at +5.5%). In this context, we favour Metso for its better positioning (greenfield pipeline and infrastructures) and continued improvement in its profitability...

 PRESS RELEASE

Danone: Information on the total number of voting rights and shares

Danone: Information on the total number of voting rights and shares DANONE French Société anonyme with a capital of €170,348,620.75.Registered Office: 59-61, rue La Fayette, 75009 Paris.Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) DateTotal number of sharesTotal number of voting rights30/11/2025681,394...

 PRESS RELEASE

DANONE : Informations relatives au nombre total de droits de vote et d...

DANONE : Informations relatives au nombre total de droits de vote et d’actions   DANONE Société anonyme à Conseil d’Administration au capital de 170 348 620,75 €.Siège social : 59-61, rue La Fayette, 75 009 Paris.552 032 534 R.C.S. Paris. Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers DateNombre d’actionsNombre total de droits de vote30/11/2025681 394 483Nombre de droits de vote théoriques (1) : 721 569 060Nombre de droit de votes ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch